Last updated:
ID:
41798
Start date:
22 December 2020
Project status:
Current
Principal investigator:
Professor Alison Goate
Lead institution:
Icahn School of Medicine at Mount Sinai, United States of America

A polygenic risk score, is a collective number based on variation in many genes across the genome. Although each gene contributes a small amount of risk common disorders like Alzheimer’s disease (AD) when this information is combined into a polygenic risk score and used along with other environmental risks their predictive value improves substantially. In this proposal, we plan to test whether genetic risk for other traits and diseases, singly or in combination, are causally linked to risk for AD. This will help us identify people at high risk for AD and also identify traits that are associated with improved survival or delayed onset of AD. Together this information will provide clues about the underlying disease mechanisms leading to improved prediction of risk, as well as improved management and treatment of disease. Our initial estimate is that we should be able to complete the project in 3-5 years.